amiodarone has been researched along with Cancer of Ovary in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belur Nagaraj, A | 1 |
| Joseph, P | 1 |
| Kovalenko, O | 1 |
| Wang, Q | 1 |
| Xu, R | 1 |
| DiFeo, A | 1 |
1 other study available for amiodarone and Cancer of Ovary
| Article | Year |
|---|---|
Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer.
Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Female; Humans; Neoplastic Stem Cells; Ovarian Neop | 2018 |